Cytokine Alteration In Multiple Myeloma (MM) Patients and Bisphosphonate (BP)-Related Osteonecrosis Of The Jaw (BRONJ)

被引:1
|
作者
Badros, Ashraf
Philip, Sunita
Lesho, Patricia
Sadowska, Mariola
Weikel, Dianna
Meiller, Timothy
Lapidus, Rena
Hester, Lisa
Milliron, Todd
Goloubeva, Olga
机构
关键词
D O I
10.1182/blood.V122.21.3153.3153
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3153
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Evolution of Bisphosphonates Related Osteonecrosis of the Jaw (BRONJ) in Patients with Multiple Myeloma (MM): A Retrospective Study.
    Andriani, Alessandro A. A. Alessandro
    Petrucci, Maria Teresa M. T. P.
    Caravita, Tommaso
    Montanaro, Marco
    Pisani, Francesco
    Coppetelli, Ugo
    De Muro, Marianna
    Bongarzoni, Velia
    Avvisati, Giuseppe
    Villiva, Nicoletta
    Levi, Anna
    Siniscalchi, A.
    Agrillo, Alessandro
    Gaglioti, Domenico
    BLOOD, 2008, 112 (11) : 935 - 935
  • [2] Bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma
    Infante Cossio, Pedro
    Cabezas Macian, Antonio
    Perez Ceballos, Jose Luis
    Palomino Nicas, Julian
    Gutierrez Perez, Jose Luis
    MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2008, 13 (01): : E52 - E57
  • [3] Interventions for treating bisphosphonate-related osteonecrosis of the jaw (BRONJ)
    Rollason, Victoria
    Laverriere, Alexandra
    MacDonald, Laura C. I.
    Walsh, Tanya
    Tramer, Martin R.
    Vogt-Ferrier, Nicole B.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (02):
  • [4] Guidelines for the diagnosis of bisphosphonate-related osteonecrosis of the jaw (BRONJ)
    Ruggiero, Salvatore L.
    CLINICAL CASES IN MINERAL AND BONE METABOLISM, 2007, 4 (01) : 37 - 42
  • [5] Conservative Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma Patients
    Melea, Pelagia I.
    Melakopoulos, Ioannis
    Kastritis, Efstathios
    Tesseromatis, Christina
    Margaritis, Vasileios
    Dimopoulos, Meletios A.
    Terpos, Evangelos
    INTERNATIONAL JOURNAL OF DENTISTRY, 2014, 2014
  • [6] Risk factors for bisphosphonate-related osteonecrosis of jaw in multiple myeloma patients
    Cafro, A. M.
    Babarano, L.
    Nichelatti, M.
    D'Avanzo, G.
    Gaglioti, D.
    Taroni, A.
    Riva, F.
    Nosari, A.
    Andriani, A.
    Morra, E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 215 - 216
  • [7] Development of a Rat Yodel of Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ)
    Marino, Karen L.
    Zakhary, Ibrahim
    Abdelsayed, Rafik A.
    Carter, Jared A.
    O'Neill, Jack C.
    Khashaba, Rania M.
    Elsalanty, Mohammed
    Stevens, Mark R.
    Borke, James L.
    JOURNAL OF ORAL IMPLANTOLOGY, 2012, 38 (01) : 511 - 518
  • [8] Interruption of bisphosphonates (BP) therapy in multiple myeloma (MM) patients and osteonecrosis of the jaw (ONJ).
    Badros, Ashraf
    Goloubeva, Olga
    Weikel, Dianna
    Rapoport, Aaron P.
    Akpek, Gorgun
    Yanovich, Saul
    Meiller, Timothy
    Sausville, Edward
    BLOOD, 2006, 108 (11) : 345B - 345B
  • [9] Novel insight into the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ)
    Kishimoto, Hiromitsu
    Noguchi, Kazuma
    Takaoka, Kazuki
    JAPANESE DENTAL SCIENCE REVIEW, 2019, 55 (01) : 95 - 102
  • [10] Successful treatment of Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) patients with sitafloxacin: New strategies for the treatment of BRONJ
    Ikeda, Tetsuya
    Kuraguchi, Jun
    Kogashiwa, Yasunao
    Yokoi, Hidenori
    Satomi, Takafumi
    Kohno, Naoyuki
    BONE, 2015, 73 : 217 - 222